Naveen Pemmaraju/X
Nov 3, 2024, 16:04
Naveen Pemmaraju: Reflecting on the tremendous time spent and powerful discussions at Binaytara Foundation Heme Summit
Naveen Pemmaraju shared on X:
“Reflecting on the tremendous time spent and powerful discussions with friends and colleagues at Binaytara Foundation Heme Summit organized by Dr Soni Smith.”
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 06:50
Apr 18, 2025, 03:14
Apr 18, 2025, 03:06
Apr 18, 2025, 02:16